The pharmaceutical industry has become one of the strategic business cards for rapid development in many parts of the country. In the pharmaceutical industry, the biomedical industry is an important priority area for many provinces and cities. In order to achieve the effect of developing biomedicine, various provinces and municipalities have invested a lot of energy to create a highland of biomedical industry development in order to form a complete industrial chain. 10 key biomedical projects in Banan District of Chongqing started to work On August 3, the Banan District of Chongqing Municipality held a concentrated start of 2018 investment projects. In the main venue of Chongqing Biomedical Industrial Park (Chongqing Maliuyanjiang Development Zone), 10 key biomedical projects such as Peking University Medical , Sichuan New Green and Chuan'an Pharmaceutical Industry Base started construction, setting a new number of Chongqing biomedical enterprises in one operation in recent years. new record. This also marks a comprehensive acceleration of the transformation and upgrading of the industrialization in Banan. The biomedical industry has increased the "throttle", the engine roared, and accelerated into the fast lane of development. According to the relevant person in charge, these 10 projects cover biopharmaceuticals, chemical raw materials and preparations, modern Chinese medicines, and high-end medical equipment, which will form a complete industrial chain, which will not only achieve resource sharing, but also form a virtuous cycle of supply, ultimately achieving mutual benefit. effect. In order to achieve this effect better, Banan District has built a Chongqing bio-pharmaceutical industrial park, which will further accelerate the pace of industrial development. Jiangxi Yongfeng County vigorously promotes the development of biomedical industry The biomedical industry is one of the three pillar industries in Yongfeng County. In recent years, Yongfeng County has promoted the development strategy of “making large-scale productive enterprises, doing live medical trade markets and realizing medicinal materials basesâ€, focusing on “supporting large projects, cultivating large enterprises, building large clusters, and building big brandsâ€. The scale of the bio-pharmaceutical industry has grown from small to large, and the structure has grown from single to multiple, forming a cluster of biomedical industries such as Chinese medicine oral liquid, tablets, medical devices, health products, and pesticides. It is reported that from 2013 to 2017, the income of the main business of the bio-pharmaceutical industry in Yongfeng County has doubled in four years, and the tax revenue has quadrupled in four years. In the first half of this year, Yongfeng County's bio-pharmaceutical industry's main business income was 1.58 billion yuan, accounting for 19.7% of the scale of industry, and paid taxes of 98.12 million yuan, accounting for 28.1% of the scale industry. Pudong biomedical industry development continues to add new kinetic energy It is reported that the joint development model of Pudong Biomedical Enterprises and the “International Advantage Resources†is increasingly increasing. A number of corporate cooperative R&D projects have been accepted by the State Drug Administration and approved for clinical research. For example, Vorolanib, a new drug company of Kaidaji Pharmaceutical Co., Ltd., and Kangruipu, a new drug from Shanghai Junshi Biotechnology Co., Ltd., have applied for CNDA for clinical trials of drugs for the treatment of previously untreated local progression or metastatic mucinous melanoma. Accepted. In addition, Shanghai Pharmaceutical and Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co., Ltd. jointly developed an injection group of human and animal chimeric anti-CD30 monoclonal antibody-MCC-DM1 coupling agent has also obtained the drug clinical trial approval issued by CNDA. The drug application category is for a new class of therapeutic biologics. Ganzhou Lanzhou New District to build the pillar of biomedical industry development Through strengthening scientific and technological innovation and improving the industrial chain, Lanzhou New District has significantly enhanced the strength of biomedical enterprises and further consolidated the biomedical industry. At present, Lanzhou New District has initially formed a group of bio-pharmaceutical pillar enterprises led by Heshengtang and Foci, and the biopharmaceutical industry gathering situation has begun to appear. According to the introduction of relevant personnel, the bio-pharmaceutical industry in Lanzhou New District is gradually forming a complete industrial chain, adhering to the goal of high-end, large-scale and international development. It will be guided by the research and development of high-quality varieties and the construction of specialized industrial parks. Support and accelerate the development of biotechnology drugs. It is reported that in 2017, Lanzhou New District biomedical industry completed an output value of 520 million yuan, accounting for 1.76% of the total industrial output value; completed value added of 87 million yuan, accounting for 1.74% of industrial added value. In the future development, the completion value of the biomedical industry in Lanzhou New District will also show a multiplier growth trend. Various products of beard covers, providing product images and basic parameters with each beard covers and High Quality beard covers; We are a professional Chinese manufacturer of beard covers, and look forward to your cooperation! Beard Guard,Beard Net,Beard Net,Disposable Non Woven Face Cover,anti falling beard cover, breathable beard cover Jiangsu Asbao Medical Technology Co., Ltd. , https://www.iigloves.com